Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of chronic morbidity and mortality worldwide. While inhaled bronchodilators, corticosteroids, and pulmonary rehabilitation manage symptoms effectively in mild to moderate stages, patients with end-stage COPD and severe bullous emphysema eventually reach a physiological point where airflow limitation becomes irreversibly debilitating.
For these patients, a lung transplant performed at an accredited centre like KIMS Super Speciality Hospital, Bangalore offers significant symptom relief, improved functional capacity, and extended life expectancy. Below, Dr. Pavan Yadav M.V., leading Lung Transplant Specialist in Bangalore, explains when medical treatment must transition toward surgical evaluation.
Clinical Indicators for Lung Transplant Referral in COPD
The International Society for Heart and Lung Transplantation (ISHLT) recommends that COPD patients be referred for transplant evaluation when they meet any of the following clinical thresholds:
- BODE Index Score ≥ 5: Calculated using Body-mass index, degree of airflow Obstruction (FEV1), Dyspnea score (mMRC), and 6-minute walk Exercise distance. Patients with a score of 7 to 10 have an estimated 2-year mortality exceeding 30-50% without surgery.
- FEV1 < 25% to 30% of predicted: Demonstrating profound expiratory airflow obstruction unresponsive to maximal bronchodilator challenge.
- Frequent Acute Exacerbations: Having three or more severe hospital admissions in a single year for acute hypercapnic respiratory failure (elevated blood CO2).
- Secondary Pulmonary Hypertension: Development of cor pulmonale (right-sided heart strain) secondary to chronic hypoxia.
The Window of Opportunity
"Transplant referral must not be delayed until the patient is completely bedbound or intubated in an ICU. The ideal window is when medical options are failing, but the patient remains strong enough to complete rigorous pulmonary rehabilitation." — Dr. Pavan Yadav – Pulmonologist & Lung Transplant Specialist
Single vs. Double Lung Transplantation for COPD
A frequent clinical decision in COPD transplant planning is whether to perform a single lung or bilateral double lung transplant:
- Single Lung Transplant (SLT): Involves replacing one diseased lung with a donor lung. Advantages include shorter surgical duration, lower blood loss, and maximal utilization of scarce donor organs. This approach is frequently favored in selected patients over 60 without pulmonary hypertension.
- Bilateral Double Lung Transplant (DLT): Replaces both lungs, completely eliminating the risk of native lung hyperinflation or pneumothorax in the residual diseased lung. Studies show superior 10-year survival rates and higher peak exercise tolerance in younger candidates undergoing double lung transplants.
Pulmonary Rehabilitation: Preserving Candidacy
Prior to transplantation, every approved candidate at KIMS Hospitals enters a structured pre-transplant pulmonary rehabilitation protocol. Supervised aerobic reconditioning, quadriceps strengthening, and nutritional optimization ensure that the patient maintains sufficient physiologic reserve to recover quickly from thoracotomy surgery.
Frequently Asked Questions About COPD Transplants
Can a former smoker receive a lung transplant for COPD?
Yes, provided the candidate has strictly maintained total smoking abstinence (including e-cigarettes and nicotine replacements) for at least 6 consecutive months prior to waitlist registration, verified by random cotinine urine tests.
How long do COPD patients live after a lung transplant?
Median post-transplant survival for COPD recipients exceeds 7 to 9 years, with many recipients surviving past 15 to 20 years with compliant immunosuppressant adherence and regular spirometry audits.
